|
[1]
|
Götze, H., Friedrich, M., Taubenheim, S., Dietz, A., Lordick, F. and Mehnert, A. (2019) Depression and Anxiety in Long-Term Survivors 5 and 10 Years after Cancer Diagnosis. Supportive Care in Cancer, 28, 211-220. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Sullivan, D.R., Forsberg, C.W., Ganzini, L., Au, D.H., Gould, M.K., Provenzale, D., et al. (2016) Longitudinal Changes in Depression Symptoms and Survival among Patients with Lung Cancer: A National Cohort Assessment. Journal of Clinical Oncology, 34, 3984-3991. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Morrison, E.J., Novotny, P.J., Sloan, J.A., Yang, P., Patten, C.A., Ruddy, K.J., et al. (2017) Emotional Problems, Quality of Life, and Symptom Burden in Patients with Lung Cancer. Clinical Lung Cancer, 18, 497-503. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Leung, B., Laskin, J., Wu, J., Bates, A. and Ho, C. (2019) Assessing the Psychosocial Needs of Newly Diagnosed Patients with Nonsmall Cell Lung Cancer: Identifying Factors Associated with Distress. Psycho-Oncology, 28, 815-821. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Pan, L.A., Martin, P., Zimmer, T., Segreti, A.M., Kassiff, S., McKain, B.W., et al. (2017) Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients with Treatment-Refractory Depression and Suicidal Behavior. American Journal of Psychiatry, 174, 42-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Didkowska, J., Wojciechowska, U., Mańczuk, M. and Łobaszewski, J. (2016) Lung Cancer Epidemiology: Contemporary and Future Challenges Worldwide. Annals of Translational Medicine, 4, 150-150. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Walker, J., Hansen, C.H., Martin, P., Symeonides, S., Ramessur, R., Murray, G., et al. (2014) Prevalence, Associations, and Adequacy of Treatment of Major Depression in Patients with Cancer: A Cross-Sectional Analysis of Routinely Collected Clinical Data. The Lancet Psychiatry, 1, 343-350. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Dai, J., Liao, N., Shi, J. and Tao, J.Q. (2017) Study of Prevalence and Influencing Factors of Depression in Tumor Patients and the Therapeutic Effects of Fluoxetine. European Review for Medical and Pharmacological Sciences, 21, 4966-4974.
|
|
[9]
|
Kroenke, K., Spitzer, R.L. and Williams, J.B.W. (2001) The PHQ-9. Journal of General Internal Medicine, 16, 606-613. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Manea, L., Gilbody, S. and McMillan, D. (2011) Optimal Cut-Off Score for Diagnosing Depression with the Patient Health Questionnaire (PHQ-9): A Meta-Analysis. Canadian Medical Association Journal, 184, E191-E196. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Annunziata, M.A., Muzzatti, B., Bidoli, E., Flaiban, C., Bomben, F., Piccinin, M., et al. (2019) Hospital Anxiety and Depression Scale (HADS) Accuracy in Cancer Patients. Supportive Care in Cancer, 28, 3921-3926. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Wu, Y., Levis, B., Sun, Y., He, C., Krishnan, A., Neupane, D., et al. (2021) Accuracy of the Hospital Anxiety and Depression Scale Depression Subscale (HADS-D) to Screen for Major Depression: Systematic Review and Individual Participant Data Meta-Analysis. BMJ, 373, n972. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Richter, P., Werner, J., Heerlein, A., Kraus, A. and Sauer, H. (1998) On the Validity of the Beck Depression Inventory. Psychopathology, 31, 160-168. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Zung, W.W.K. (1965) A Self-Rating Depression Scale. Archives of General Psychiatry, 12, 63-70. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Dunstan, D.A., Scott, N. and Todd, A.K. (2017) Screening for Anxiety and Depression: Reassessing the Utility of the Zung Scales. BMC Psychiatry, 17, Article No. 329. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Sotelo, J.L., Musselman, D. and Nemeroff, C. (2014) The Biology of Depression in Cancer and the Relationship between Depression and Cancer Progression. International Review of Psychiatry, 26, 16-30. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A. and Cleare, A.J. (2015) Inflammation and Clinical Response to Treatment in Depression: A Meta-Analysis. European Neuropsychopharmacology, 25, 1532-1543. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Akil, H., Gordon, J., Hen, R., Javitch, J., Mayberg, H., McEwen, B., et al. (2018) Treatment Resistant Depression: A Multi-Scale, Systems Biology Approach. Neuroscience & Biobehavioral Reviews, 84, 272-288. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
McFarland, D.C., Jutagir, D.R., Rosenfeld, B., Pirl, W., Miller, A.H., Breitbart, W., et al. (2019) Depression and Inflammation among Epidermal Growth Factor Receptor (EGFR) Mutant Nonsmall Cell Lung Cancer Patients. Psycho-Oncology, 28, 1461-1469. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
McFarland, D.C., Breitbart, W., Miller, A.H. and Nelson, C. (2020) Depression and Inflammation in Patients with Lung Cancer: A Comparative Analysis of Acute Phase Reactant Inflammatory Markers. Psychosomatics, 61, 527-537. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Giannousi, Z., Gioulbasanis, I., Pallis, A.G., Xyrafas, A., Dalliani, D., Kalbakis, K., et al. (2011) Nutritional Status, Acute Phase Response and Depression in Metastatic Lung Cancer Patients: Correlations and Association Prognosis. Supportive Care in Cancer, 20, 1823-1829. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Colotta, F., Allavena, P., Sica, A., Garlanda, C. and Mantovani, A. (2009) Cancer-Related Inflammation, the Seventh Hallmark of Cancer: Links to Genetic Instability. Carcinogenesis, 30, 1073-1081. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Kappelmann, N., Lewis, G., Dantzer, R., Jones, P.B. and Khandaker, G.M. (2016) Antidepressant Activity of Anti-Cytokine Treatment: A Systematic Review and Meta-Analysis of Clinical Trials of Chronic Inflammatory Conditions. Molecular Psychiatry, 23, 335-343. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Chen, X., DuBois, D.C., Almon, R.R. and Jusko, W.J. (2017) Interrelationships between Infliximab and Recombinant Tumor Necrosis Factor-αin Plasma Using Minimal Physiologically Based Pharmacokinetic Models. Drug Metabolism and Disposition, 45, 790-797. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Hung, K.C., Wu, C.C., Chen, H.S., Ma, W.Y., Tseng, C.F., Yang, L.K., et al. (2010) Serum IL-6, Albumin and Comorbidities Are Closely Correlated with Symptoms of Depression in Patients on Maintenance Haemodialysis. Nephrology Dialysis Transplantation, 26, 658-664. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Valkanova, V., Ebmeier, K.P. and Allan, C.L. (2013) CRP, IL-6 and Depression: A Systematic Review and Meta-Analysis of Longitudinal Studies. Journal of Affective Disorders, 150, 736-744. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Jha, M. and Trivedi, M. (2018) Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation. International Journal of Molecular Sciences, 19, Article 233. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Howren, M.B., Lamkin, D.M. and Suls, J. (2009) Associations of Depression with C-Reactive Protein, IL-1, and IL-6: A Meta-analysis. Psychosomatic Medicine, 71, 171-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Goel, P., Kulkarni, K., Rashmi, N., Galhotra, V., Rajguru, J.P. and Jha, S.K. (2017) Assessment of C-Reactive Proteins, Cytokines, and Plasma Protein Levels in Hypertensive Patients with Apical Periodontitis. The Journal of Contemporary Dental Practice, 18, 516-521. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Jin, J., Hu, K., Zhou, Y. and Li, W. (2017) Clinical Utility of the Modified Glasgow Prognostic Score in Lung Cancer: A Meta-analysis. PLOS ONE, 12, e0184412. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Shrotriya, S., Walsh, D., Nowacki, A.S., Lorton, C., Aktas, A., Hullihen, B., et al. (2018) Serum C-Reactive Protein Is an Important and Powerful Prognostic Biomarker in Most Adult Solid Tumors. PLOS ONE, 13, e0202555. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
McFarland, D.C., Miller, A.H. and Nelson, C. (2020) A Longitudinal Analysis of Inflammation and Depression in Patients with Metastatic Lung Cancer: Associations with Survival. Biological Research for Nursing, 23, 301-310. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
McFarland, D.C., Fernbach, M., Breitbart, W.S. and Nelson, C. (2020) Prognosis in Metastatic Lung Cancer: Vitamin D Deficiency and Depression—A Cross-Sectional Analysis. BMJ Supportive & Palliative Care, 12, 339-346. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Jha, M.K., Minhajuddin, A., Gadad, B.S., Greer, T., Grannemann, B., Soyombo, A., et al. (2017) Can C-Reactive Protein Inform Antidepressant Medication Selection in Depressed Outpatients? Findings from the CO-MED Trial. Psychoneuroendocrinology, 78, 105-113. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
McFarland, D.C., Jutagir, D.R., Miller, A.H., Breitbart, W., Nelson, C. and Rosenfeld, B. (2020) Tumor Mutation Burden and Depression in Lung Cancer: Association with Inflammation. Journal of the National Comprehensive Cancer Network, 18, 434-442. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
de Oliveira, C., Hirani, V. and Biddulph, J.P. (2017) Associations between Vitamin D Levels and Depressive Symptoms in Later Life: Evidence from the English Longitudinal Study of Ageing (ELSA). The Journals of Gerontology: Series A, 73, 1377-1382. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
An, E., Lo, C., Hales, S., Zimmermann, C. and Rodin, G. (2018) Demoralization and Death Anxiety in Advanced Cancer. Psycho-Oncology, 27, 2566-2572. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Grossman, C.H., Brooker, J., Michael, N. and Kissane, D. (2017) Death Anxiety Interventions in Patients with Advanced Cancer: A Systematic Review. Palliative Medicine, 32, 172-184. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Eggen, A.C., Reyners, A.K.L., Shen, G., Bosma, I., Jalving, M., Leighl, N.B., et al. (2020) Death Anxiety in Patients with Metastatic Non-Small Cell Lung Cancer with and without Brain Metastases. Journal of Pain and Symptom Management, 60, 422-429.e1. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Pyszczynski, T., Greenberg, J., Solomon, S., Arndt, J. and Schimel, J. (2004) Why Do People Need Self-Esteem? A Theoretical and Empirical Review. Psychological Bulletin, 130, 435-468. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Rodin, G., Lo, C., Rydall, A., Shnall, J., Malfitano, C., Chiu, A., et al. (2018) Managing Cancer and Living Meaningfully (CALM): A Randomized Controlled Trial of a Psychological Intervention for Patients with Advanced Cancer. Journal of Clinical Oncology, 36, 2422-2432. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Devins, G.M. (2010) Using the Illness Intrusiveness Ratings Scale to Understand Health-Related Quality of Life in Chronic Disease. Journal of Psychosomatic Research, 68, 591-602. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Gonzalez-Ling, A., Galindo Vázquez, O., Espinoza Bello, M., Robles, R., Rascón-Gasca, M.L., Lara-Mejía, L., et al. (2022) Quality of Life, Anxiety, Depression, and Distress in Patients with Advanced and Metastatic Lung Cancer. Palliative and Supportive Care, 21, 608-615. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
McFarland, D.C. (2020) A Response to “Psychological Symptoms and Survival in Patients with Metastatic Lung Cancer: Smoking Must Be the First Concern!”. Psycho-Oncology, 29, 1504-1505. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
LeBlanc, T.W., Samsa, G.P., Wolf, S.P., Locke, S.C., Cella, D.F. and Abernethy, A.P. (2015) Validation and Real-World Assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) Scale in Patients with Advanced Non-Small Cell Lung Cancer and the Cancer Anorexia-Cachexia Syndrome (CACS). Supportive Care in Cancer, 23, 2341-2347. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Chabowski, M., Polański, J., Jankowska-Polańska, B., Janczak, D. and Rosińczuk, J. (2018) Is Nutritional Status Associated with the Level of Anxiety, Depression and Pain in Patients with Lung Cancer? Journal of Thoracic Disease, 10, 2303-2310. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
McFarland, D.C., Nelson, C. and Miller, A.H. (2020) Early Childhood Adversity in Adult Patients with Metastatic Lung Cancer: Cross-Sectional Analysis of Symptom Burden and Inflammation. Brain, Behavior, and Immunity, 90, 167-173. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Siegel, R.L., Miller, K.D. and Jemal, A. (2019) Cancer Statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7-34. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
McFarland, D.C., Jutagir, D.R., Rosenfeld, B. and Nelson, C.J. (2019) Physiological and Psychological Associations of Early Childhood Adversity in Lung Cancer. Journal of Clinical Oncology, 37, 80. [Google Scholar] [CrossRef]
|